Literature DB >> 25859755

Normalization of CEA Levels Post-Neoadjuvant Therapy is a Strong Predictor of Pathologic Complete Response in Rectal Cancer.

Ariella Kleiman1, Ahmed Al-Khamis, Ali Farsi, Abbas Kezouh, Te Vuong, Philip H Gordon, Carol-Ann Vasilevsky, Nancy Morin, Julio Faria, Gabriela Ghitulescu, Marylise Boutros.   

Abstract

BACKGROUND: Recent attention has been focused on the relationship between carcinoembryonic antigen (CEA) and pathological complete response (pCR), without consensus regarding its predictive value. This study aims to examine the association between CEA and pCR.
METHODS: We conducted a retrospective review of a prospectively maintained database of all patients who underwent primary rectal cancer resection after neo-adjuvant chemoradiotherapy (nCRT). Patients were divided into two groups, pCR or no-pCR, based on final pathology. CEA levels were measured at the initial visit with the surgeon/oncologist and post-completion of nCRT.
RESULTS: One hundred and forty-one patients underwent primary rectal cancer resections after nCRT. Nineteen patients (13.5 %) achieved pCR, while 122 (86.5 %) had no-pCR. Pre-nCRT CEA levels were not significantly different between groups (2.75 vs 4.5 μg/L, p = 0.65). However, post-nCRT CEA levels were significantly lower in patients with pCR (1.7 vs 2.4 μg/L, p < 0.01). On multivariate logistic regression analyses, low post-nCRT CEA level was an independent predictor of pCR (OR 1.74, CI 1.06, 3.81) and normalization of CEA from an initially elevated level was a highly significant predictor of pCR (OR 64.8, CI 2.53, 18,371).
CONCLUSION: Low post-nCRT CEA is an independent predictor of pCR, and normalization of CEA post-nCRT is a strong predictor of pCR.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25859755     DOI: 10.1007/s11605-015-2814-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  24 in total

1.  Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management?

Authors:  Angelita Habr-Gama; Jorge Sabbaga; Joaquim Gama-Rodrigues; Guilherme P São Julião; Igor Proscurshim; Patricia Bailão Aguilar; Wladimir Nadalin; Rodrigo O Perez
Journal:  Dis Colon Rectum       Date:  2013-10       Impact factor: 4.585

2.  Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients.

Authors:  Carlo Capirci; Vincenzo Valentini; Luca Cionini; Antonino De Paoli; Claus Rodel; Robert Glynne-Jones; Claudio Coco; Mario Romano; Giovanna Mantello; Silvia Palazzi; Falchetti Osti Mattia; Maria Luisa Friso; Domenico Genovesi; Cristiana Vidali; Maria Antonietta Gambacorta; Alberto Buffoli; Marco Lupattelli; Maria Silvia Favretto; Giuseppe La Torre
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-11       Impact factor: 7.038

3.  Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer.

Authors:  Jung Wook Huh; Hyeong Rok Kim; Young Jin Kim
Journal:  Dis Colon Rectum       Date:  2013-06       Impact factor: 4.585

4.  High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects.

Authors:  Té Vuong; Slobodan Devic; Belal Moftah; Michael Evans; Ervin B Podgorsak
Journal:  Brachytherapy       Date:  2005       Impact factor: 2.362

5.  A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision.

Authors:  Julio García-Aguilar; Enrique Hernandez de Anda; Prayuth Sirivongs; Suk-Hwan Lee; Robert D Madoff; David A Rothenberger
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

6.  Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Gregory Wynn; John Marks; Hermann Kessler; Joaquim Gama-Rodrigues
Journal:  Dis Colon Rectum       Date:  2010-12       Impact factor: 4.585

7.  Response to neoadjuvant therapy in patients with early age-of-onset rectal cancer.

Authors:  Emily Steinhagen; Jinru Shia; Elyn Riedel; Garrett M Nash; Martin R Weiser; Larissa K Temple; Phillip B Paty; José G Guillem
Journal:  Dis Colon Rectum       Date:  2013-01       Impact factor: 4.585

8.  Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer.

Authors:  Matthew F Kalady; Luiz Felipe de Campos-Lobato; Luca Stocchi; Daniel P Geisler; David Dietz; Ian C Lavery; Victor W Fazio
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

9.  The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.

Authors:  Rodrigo O Perez; Guilherme P São Julião; Angelita Habr-Gama; Desidério Kiss; Igor Proscurshim; Fabio Guilherme Campos; Joaquim J Gama-Rodrigues; Ivan Cecconello
Journal:  Dis Colon Rectum       Date:  2009-06       Impact factor: 4.585

10.  [Multivariate analysis of clinicopathologic factors correlated with pathological complete response following preoperative radiotherapy in rectal adenocarcinoma].

Authors:  Jun-Zhong Lin; Zhi-Zhong Pan; Zhi-Fan Zeng; Pei-Rong Ding; De-Sen Wan
Journal:  Ai Zheng       Date:  2009-09
View more
  25 in total

Review 1.  Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review.

Authors:  Byong Chul Yoo; Seung-Gu Yeo
Journal:  EPMA J       Date:  2017-03-03       Impact factor: 6.543

2.  Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.

Authors:  Sunil V Patel; Campbell S Roxburgh; Efsevia Vakiani; Jinru Shia; J Joshua Smith; Larissa K Temple; Philip Paty; Julio Garcia-Aguilar; Garrett Nash; Jose Guillem; Abraham Wu; Marsha Reyngold; Martin R Weiser
Journal:  J Surg Oncol       Date:  2016-09-19       Impact factor: 3.454

3.  Pathologic response following treatment for locally advanced rectal cancer: Does location matter?

Authors:  William H Ward; Elin R Sigurdson; Andrew C Esposito; Karen J Ruth; Samuel M Manstein; Eric C Sorenson; Brian D Wernick; Jeffrey M Farma
Journal:  J Surg Res       Date:  2018-01-04       Impact factor: 2.192

4.  Relations of Changes in Serum Carcinoembryonic Antigen Levels before and after Neoadjuvant Chemoradiotherapy and after Surgery to Histologic Response and Outcomes in Patients with Locally Advanced Rectal Cancer.

Authors:  Gota Saito; Sotaro Sadahiro; Takashi Ogimi; Hiroshi Miyakita; Kazutake Okada; Akira Tanaka; Toshiyuki Suzuki
Journal:  Oncology       Date:  2017-12-22       Impact factor: 2.935

Review 5.  Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature.

Authors:  Sami A Chadi; Marianna Berho; Steven D Wexner
Journal:  Langenbecks Arch Surg       Date:  2015-08-07       Impact factor: 3.445

Review 6.  Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis.

Authors:  Giuseppe Colloca; Antonella Venturino; Pasquale Vitucci
Journal:  Med Oncol       Date:  2017-09-07       Impact factor: 3.064

7.  Watch and Wait?--Elevated Pretreatment CEA Is Associated with Decreased Pathological Complete Response in Rectal Cancer.

Authors:  Christian P Probst; Adan Z Becerra; Christopher T Aquina; Mohamedtaki A Tejani; Bradley J Hensley; Maynor G González; Katia Noyes; John R T Monson; Fergal J Fleming
Journal:  J Gastrointest Surg       Date:  2015-11-06       Impact factor: 3.452

8.  Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.

Authors:  Eisar Al-Sukhni; Kristopher Attwood; David M Mattson; Emmanuel Gabriel; Steven J Nurkin
Journal:  Ann Surg Oncol       Date:  2015-12-14       Impact factor: 5.344

9.  Clinicopathologic determinants of pathologic treatment response in neoadjuvant treated rectal adenocarcinoma.

Authors:  Iván González; Philip S Bauer; William C Chapman; Zahra Alipour; Rehan Rais; Jingxia Liu; Deyali Chatterjee
Journal:  Ann Diagn Pathol       Date:  2019-12-14       Impact factor: 2.090

10.  Impact of delaying surgery after chemoradiation in rectal cancer: outcomes from a tertiary cancer centre in India.

Authors:  Praveen Kammar; Aditi Chaturvedi; Masillamany Sivasanker; Ashwin de'Souza; Reena Engineer; Vikas Ostwal; Avanish Saklani
Journal:  J Gastrointest Oncol       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.